Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer

被引:0
作者
Yinjun He
Xiang Zhang
Ming Zhu
Wenguang He
Hanju Hua
Feng Ye
Xile Zhou
Nan Chen
Yandong Li
Weixiang Zhong
Guosheng Wu
Hui Cai
Weiqin Jiang
机构
[1] Zhejiang University School of Medicine,Department of Colorectal Surgery, First Affiliated Hospital
[2] Zhejiang University,College of Medicine
[3] Gansu Provincial Hospital,General Surgery Clinical Medical Center
[4] The First Clinical Medical College of Lanzhou University,Department of Radiology, First Affiliated Hospital
[5] Zhejiang University School of Medicine,Department of Colorectal Surgery
[6] Yuyao Hospital of Traditional Chinese Medicine,Department of Pathology, First Affiliated Hospital
[7] Zhejiang University School of Medicine,undefined
来源
Journal of Translational Medicine | / 21卷
关键词
sPD-L1; Colorectal cancer; Biomarker; Combination immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 326 条
[41]  
Travis WD(2014)High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial Leukemia 28 421-undefined
[42]  
Rekhtman N(2019)A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression Cancer Immunol Immunother CII 68 55-undefined
[43]  
Rozenblit M(2017)Origins of lymphatic and distant metastases in human colorectal cancer Science 357 93-undefined
[44]  
Huang R(2022)Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors Genome Med 14 1924-undefined
[45]  
Danziger N(2022)Lymph node colonization induces tumor-immune tolerance to promote distant metastasis Cell 185 798-undefined
[46]  
Hegde P(2022)Immune suppression in the tumor-draining lymph node corresponds with distant disease recurrence in patients with melanoma Cancer Cell 40 e1310358-undefined
[47]  
Alexander B(2020)Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours ESMO Open 5 107467-undefined
[48]  
Ramkissoon S(2017)Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer Oncoimmunology 6 982-undefined
[49]  
Zhang X(2021)Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma Int Immunopharmacol 94 78-undefined
[50]  
Yin X(2019)Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer J Exp Med 216 563-undefined